Cargando…
Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye
BACKGROUND: The aim of this research is to initiate a 5-year natural history study of dry eye disease (DED) using objectively assessed and patient-reported outcomes, to explore the hypothesis that DED is a progressive condition that has substantive and measurable impacts not only on the ocular surfa...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746001/ https://www.ncbi.nlm.nih.gov/pubmed/29284427 http://dx.doi.org/10.1186/s12886-017-0646-5 |
_version_ | 1783289023090917376 |
---|---|
author | McDonnell, Peter J. Pflugfelder, Stephen C. Stern, Michael E. Hardten, David R. Conway, Taryn Villanueva, Linda Hollander, David A. |
author_facet | McDonnell, Peter J. Pflugfelder, Stephen C. Stern, Michael E. Hardten, David R. Conway, Taryn Villanueva, Linda Hollander, David A. |
author_sort | McDonnell, Peter J. |
collection | PubMed |
description | BACKGROUND: The aim of this research is to initiate a 5-year natural history study of dry eye disease (DED) using objectively assessed and patient-reported outcomes, to explore the hypothesis that DED is a progressive condition that has substantive and measurable impacts not only on the ocular surface, but on quality of life and visual functioning. Our objective for this report is to examine the baseline data. METHODS: A multicenter, prospective, controlled, observational study of Level 2 (mild-to-moderate) DED patients based on International Task Force Delphi Panel severity grading, and controls, documented baseline measures (including tear film biomarkers and quality of life). Tear cytokine concentrations were also measured in the tear film. Patients were using artificial tears as needed. RESULTS: Two hundred seventeen DED patients and 67 gender- and age-matched controls were enrolled. A majority were females and Caucasian and groups did not differ significantly in terms of gender, race, or age. Differences between DED and matched controls, at baseline, included mean scores for Ocular Surface Disease Index (31.7 vs 4.1, P < 0.0001), Schirmer test (5.7 vs 15.3 mm, P < 0.0001), corneal staining (1.4 vs 0.2, P < 0.0001), conjunctival staining (1.4 vs 0.3, P < 0.0001), and tear break-up time (5.7 vs 8.5 s, P < 0.0001). Tear cytokines levels were determined and included interferon-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, tumor necrosis factor-α, epidermal growth factor, IL-13, IL-17, IL-1α, and inducible protein-10. The mean levels of IL-8 and IL-6 were slightly higher in the DED group at baseline. Blurred vision was reported as moderate/severe/very severe at baseline in 57.6% of DED patients vs.10.5% of normal controls (P < 0.0001). DED patients reported greater reductions in work and non-work productivity, as well as greater need for visits to ophthalmologists during the prior year. CONCLUSIONS: In this report of the baseline findings of a 5-year natural history study of DED, a striking disease burden is observed with regard to blurred vision, productivity, and visits to eye care practitioners in mild to moderate DED patients compared to normal subjects of similar ages and genders. TRIAL REGISTRATION: ClinicalTrials.gov NCT00833235 on January 30, 2009. |
format | Online Article Text |
id | pubmed-5746001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57460012018-01-03 Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye McDonnell, Peter J. Pflugfelder, Stephen C. Stern, Michael E. Hardten, David R. Conway, Taryn Villanueva, Linda Hollander, David A. BMC Ophthalmol Research Article BACKGROUND: The aim of this research is to initiate a 5-year natural history study of dry eye disease (DED) using objectively assessed and patient-reported outcomes, to explore the hypothesis that DED is a progressive condition that has substantive and measurable impacts not only on the ocular surface, but on quality of life and visual functioning. Our objective for this report is to examine the baseline data. METHODS: A multicenter, prospective, controlled, observational study of Level 2 (mild-to-moderate) DED patients based on International Task Force Delphi Panel severity grading, and controls, documented baseline measures (including tear film biomarkers and quality of life). Tear cytokine concentrations were also measured in the tear film. Patients were using artificial tears as needed. RESULTS: Two hundred seventeen DED patients and 67 gender- and age-matched controls were enrolled. A majority were females and Caucasian and groups did not differ significantly in terms of gender, race, or age. Differences between DED and matched controls, at baseline, included mean scores for Ocular Surface Disease Index (31.7 vs 4.1, P < 0.0001), Schirmer test (5.7 vs 15.3 mm, P < 0.0001), corneal staining (1.4 vs 0.2, P < 0.0001), conjunctival staining (1.4 vs 0.3, P < 0.0001), and tear break-up time (5.7 vs 8.5 s, P < 0.0001). Tear cytokines levels were determined and included interferon-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, tumor necrosis factor-α, epidermal growth factor, IL-13, IL-17, IL-1α, and inducible protein-10. The mean levels of IL-8 and IL-6 were slightly higher in the DED group at baseline. Blurred vision was reported as moderate/severe/very severe at baseline in 57.6% of DED patients vs.10.5% of normal controls (P < 0.0001). DED patients reported greater reductions in work and non-work productivity, as well as greater need for visits to ophthalmologists during the prior year. CONCLUSIONS: In this report of the baseline findings of a 5-year natural history study of DED, a striking disease burden is observed with regard to blurred vision, productivity, and visits to eye care practitioners in mild to moderate DED patients compared to normal subjects of similar ages and genders. TRIAL REGISTRATION: ClinicalTrials.gov NCT00833235 on January 30, 2009. BioMed Central 2017-12-28 /pmc/articles/PMC5746001/ /pubmed/29284427 http://dx.doi.org/10.1186/s12886-017-0646-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article McDonnell, Peter J. Pflugfelder, Stephen C. Stern, Michael E. Hardten, David R. Conway, Taryn Villanueva, Linda Hollander, David A. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye |
title | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye |
title_full | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye |
title_fullStr | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye |
title_full_unstemmed | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye |
title_short | Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye |
title_sort | study design and baseline findings from the progression of ocular findings (proof) natural history study of dry eye |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746001/ https://www.ncbi.nlm.nih.gov/pubmed/29284427 http://dx.doi.org/10.1186/s12886-017-0646-5 |
work_keys_str_mv | AT mcdonnellpeterj studydesignandbaselinefindingsfromtheprogressionofocularfindingsproofnaturalhistorystudyofdryeye AT pflugfelderstephenc studydesignandbaselinefindingsfromtheprogressionofocularfindingsproofnaturalhistorystudyofdryeye AT sternmichaele studydesignandbaselinefindingsfromtheprogressionofocularfindingsproofnaturalhistorystudyofdryeye AT hardtendavidr studydesignandbaselinefindingsfromtheprogressionofocularfindingsproofnaturalhistorystudyofdryeye AT conwaytaryn studydesignandbaselinefindingsfromtheprogressionofocularfindingsproofnaturalhistorystudyofdryeye AT villanuevalinda studydesignandbaselinefindingsfromtheprogressionofocularfindingsproofnaturalhistorystudyofdryeye AT hollanderdavida studydesignandbaselinefindingsfromtheprogressionofocularfindingsproofnaturalhistorystudyofdryeye |